Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFIPAP: Efficacy of Pathogen-Reduced Platelets in Bone Marrow Aplasia
NCT01789762Phase 4Completed
- Sponsor
- Etablissement Français du Sang
- Start
- May 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amotosalen in Thrombocytopenia, sponsored by Etablissement Français du Sang. Started May 2013; status: completed.
02
Drugs
amotosalen
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01789762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01789762.